This trial will test if angiotensin-(1-7) can help improve cardiovascular health for people with obesity and high blood pressure.
1 Primary · 5 Secondary · Reporting Duration: 30 minutes
Experimental Treatment
Non-Treatment Group
24 Total Participants · 2 Treatment Groups
Primary Treatment: Angiotensin-(1-7) · Has Placebo Group · Phase < 1
Age 18 - 60 · All Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Pennsylvania | 100.0% |
18 - 65 | 100.0% |
Penn State College of Medicine | 100.0% |
Met criteria | 100.0% |
100.0% | |